Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.

Cancer - 15 Mar 2000

Abendstein B, Marth C, Müller-Holzner E, Widschwendter M, Daxenbichler G, Zeimet A G

Abstract excerpt

BACKGROUND: Accumulation of mutated p53 in malignant cells can lead to the generation of anti-p53 autoantibodies in the serum and other body fluids of cancer patients. This retrospective study was performed to evaluate the prognostic significance of preoperative serum and ascitic anti-p53 antibodies in advanced ovarian carcinoma. METHODS: In 113 ovarian carcinoma patients who presented with significant amounts of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ascites
Share to Autoantibodies
Share to Carcinoma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Enzyme-Linked Immunosorbent Assay

Share to Forecasting

Share to Proportional Hazards Models

Share to Regression Analysis

Source

Identifiers

PMID: 10717627
DOI: 10.1002/(sici)1097-0142(20000315)88:6<1432::aid-cncr22>3.0.co;2-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.PMID 10717627Read ↗

Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.Semantic proximity Read ↗

[Clinical importance of serum anti-p53 antibodies as tumor markers].Semantic proximity Read ↗

Serum anti-p53 antibodies as a useful marker for prognosis of gastric carcinoma.Semantic proximity Read ↗

p53 genetic alterations, protein expression and autoantibodies in human colorectal carcinoma: A comparative study.Semantic proximity Read ↗

[Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma].Semantic proximity Read ↗

Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients.Semantic proximity Read ↗

Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma.Semantic proximity Read ↗

Serum anti-p53 antibodies in uterine and ovarian cancer: association with dna sequence copy number abnormalities.Semantic proximity Read ↗

The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.Semantic proximity Read ↗

p53 gene mutation, tumor p53 protein overexpression, and serum p53 autoantibody generation in patients with breast cancer.Semantic proximity Read ↗

Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India.Semantic proximity Read ↗

Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.